322 related articles for article (PubMed ID: 11086090)
1. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense.
Chen GH; Reddy RC; Newstead MW; Tateda K; Kyasapura BL; Standiford TJ
J Immunol; 2000 Dec; 165(11):6496-503. PubMed ID: 11086090
[TBL] [Abstract][Full Text] [Related]
2. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction.
Pène F; Zuber B; Courtine E; Rousseau C; Ouaaz F; Toubiana J; Tazi A; Mira JP; Chiche JD
J Immunol; 2008 Dec; 181(12):8513-20. PubMed ID: 19050269
[TBL] [Abstract][Full Text] [Related]
4. Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.
Hoogerwerf JJ; Leendertse M; Wieland CW; de Vos AF; de Boer JD; Florquin S; van der Poll T
Am J Respir Crit Care Med; 2011 Apr; 183(7):932-40. PubMed ID: 20959556
[TBL] [Abstract][Full Text] [Related]
5. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
[TBL] [Abstract][Full Text] [Related]
6. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10.
Reddy RC; Chen GH; Newstead MW; Moore T; Zeng X; Tateda K; Standiford TJ
Infect Immun; 2001 Mar; 69(3):1394-401. PubMed ID: 11179304
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J
J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
Pène F; Grimaldi D; Zuber B; Sauneuf B; Rousseau C; El Hachem C; Martin C; Belaïdouni N; Balloy V; Mira JP; Chiche JD
J Infect Dis; 2012 Sep; 206(6):932-42. PubMed ID: 22782952
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia.
Standiford TJ; Wilkowski JM; Sisson TH; Hattori N; Mehrad B; Bucknell KA; Moore TA
Hum Gene Ther; 1999 Apr; 10(6):899-909. PubMed ID: 10223724
[TBL] [Abstract][Full Text] [Related]
10. A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-γ production of NK cells in the lung during sepsis-induced immunosuppression.
Pastille E; Pohlmann S; Wirsdörfer F; Reib A; Flohé SB
Innate Immun; 2015 Feb; 21(2):115-26. PubMed ID: 24406749
[TBL] [Abstract][Full Text] [Related]
11. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation.
Ojielo CI; Cooke K; Mancuso P; Standiford TJ; Olkiewicz KM; Clouthier S; Corrion L; Ballinger MN; Toews GB; Paine R; Moore BB
J Immunol; 2003 Oct; 171(8):4416-24. PubMed ID: 14530368
[TBL] [Abstract][Full Text] [Related]
12. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
Jeyaseelan S; Young SK; Yamamoto M; Arndt PG; Akira S; Kolls JK; Worthen GS
J Immunol; 2006 Jul; 177(1):538-47. PubMed ID: 16785551
[TBL] [Abstract][Full Text] [Related]
13. Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression.
Chen W; Lian J; Ye JJ; Mo QF; Qin J; Hong GL; Chen LW; Zhi SC; Zhao GJ; Lu ZQ
Int Immunopharmacol; 2017 Nov; 52():61-69. PubMed ID: 28863323
[TBL] [Abstract][Full Text] [Related]
14. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia.
Mancuso P; Gottschalk A; Phare SM; Peters-Golden M; Lukacs NW; Huffnagle GB
J Immunol; 2002 Apr; 168(8):4018-24. PubMed ID: 11937559
[TBL] [Abstract][Full Text] [Related]
15. Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression.
Murphey ED; Lin CY; McGuire RW; Toliver-Kinsky T; Herndon DN; Sherwood ER
Shock; 2004 May; 21(5):415-25. PubMed ID: 15087817
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
[TBL] [Abstract][Full Text] [Related]
17. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
[TBL] [Abstract][Full Text] [Related]
18. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.
Ballinger MN; Paine R; Serezani CH; Aronoff DM; Choi ES; Standiford TJ; Toews GB; Moore BB
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):766-74. PubMed ID: 16474098
[TBL] [Abstract][Full Text] [Related]
19. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
20. Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia.
Laichalk LL; Bucknell KA; Huffnagle GB; Wilkowski JM; Moore TA; Romanelli RJ; Standiford TJ
Infect Immun; 1998 Jun; 66(6):2822-6. PubMed ID: 9596755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
